INVER GROVE HEIGHTS, Minn.--(BUSINESS WIRE)--MedicalCV, Inc. (OTCBB:MCVI), a cardiovascular surgery company, announced today that both the Company’s ATRILAZE surgical ablation system and SOLAR automated surgical ablation system were highlighted at this weekend’s NewEra Cardiac Care 2007 meeting on Saturday, January 6th, at the Hyatt Regency in Huntington Beach, California. Together, these systems represent two generations of the Company’s current laser-based tissue ablation platform; the ATRILAZE System, which presently has FDA 510(k) clearance for cardiac tissue ablation, and the SOLAR System, the application for which is in the process of being amended to seek a 510(k) clearance for soft tissue ablation from the FDA.
